Baseline Characteristics of Patients in Cholesterol Education and Research Trial
| Characteristic | Control | Intervention | P Value |
|---|---|---|---|
| Practices, No. | 15 | 15 | |
| Size, No. (%) | |||
| Solo | 8 (53) | 9 (60) | 0.71 |
| Group | 7 (47) | 6 (40) | |
| Nurse practitioner/physician’s assistant in practice, No. (%) | 5 (33) | 7 (47) | 0.46 |
| Type, No. (%) | |||
| Family practice | 8 (53) | 7 (47) | 0.72 |
| Internal medicine | 7 (47) | 8 (53) | |
| Hospital affiliated (n, %) | 2 (13) | 3 (20) | 1.00 |
| Physicians, No. | 29 | 26 | 3 |
| Age, mean (SD), y | 46.7 (6.3) | 46.4 (8.4) | 0.94 |
| Male, No. (%) | 22 (76) | 16 (62) | 0.25 |
| Years in practice, mean (SD) | 15.8 (6.9) | 15.0 (8.8) | 0.95 |
| Patients seen per week, mean (SD), No. | 99 (46) | 96 (28) | 0.39 |
| Never used PDA, No. (%) | 11 (38) | 13 (50) | 0.21 |
| Minutes behind at the end of the day, mean (SD), No. | 18 (14.1) | 23 (21.5) | 0.46 |
| Patients, No.a | 2,105 | 2,000 | 3 |
| Male, % | 41.8 | 39.7 | 0.693 |
| Marital status, % | |||
| Partnered | 71.0 | 72.3 | 0.53 |
| Not partnered | 29.0 | 27.7 | |
| Race, % | |||
| American Indian | 0.5 | 0.5 | 0.61 |
| Asian | 0.8 | 0.7 | |
| African American | 1.2 | 1.3 | |
| White | 95.7 | 95.8 | |
| Hispanic | 1.7 | 1.3 | |
| Missing | 0.3 | 0.2 | |
| CHD risk group, % | |||
| CHD equivalent | 18.4 | 21.1 | 0.33 |
| High | 9.8 | 9.2 | 0.73 |
| Moderate | 24.6 | 17.5 | 0.02 |
| Low | 44.4 | 50.4 | 0.25 |
| Current smoker, % | 13.8 | 10.8 | 0.21 |
| Physically inactive, % | 24.7 | 23.4 | 0.63 |
| At LDL cholesterol goal (%) | 58.9 | 58.4 | 0.89 |
| At non-HDL cholesterol goal, % | 62.3 | 65.5 | 0.33 |
| Diagnosed lipid disorder treated with lipid medications, % | 56.1 | 57.3 | 0.74 |
| Treatment gap for lipid management, % | 29.3 | 30.6 | 0.74 |
| Medical history, % | 3 | 3 | 3 |
| COPD | 7.6 | 5.9 | 0.40 |
| Diabetes | 9.6 | 11.2 | 0.27 |
| Hypertension | 45.6 | 41.9 | 0.40 |
| Undiagnosed hypertension | 3.2 | 3.0 | 0.80 |
| Controlled hypertension | 82.3 | 82.8 | 0.88 |
| Lipid disorder | 59.2 | 56.9 | 0.67 |
| Undiagnosed lipid disorder | 17.6 | 19.0 | 0.71 |
| Overweight | 5.9 | 8.1 | 0.31 |
| Obese | 17.1 | 17.5 | 0.91 |
| Depression | 25.8 | 25.6 | 0.96 |
| GERD | 20.7 | 22.7 | 0.51 |
| Metabolic syndrome | 0.7 | 1.6 | 0.18 |
| Family history of CHD | 38.4 | 30.2 | 0.35 |
| Living with 2 or more chronic conditions | 58.2 | 56.8 | 0.78 |
| Age, mean (SE), y | 52.3 (1.1) | 54.0 (1.1) | 0.25 |
| Total cholesterol, mean (SE), mg/dL | 193 (1.8) | 193 (1.8) | 0.88 |
| LDL cholesterol, mean (SE), mg/dL | 114 (1.6) | 114 (1.5) | 0.96 |
| HDL cholesterol, mean (SE), mg/dL | 54 (0.9) | 54 (0.9) | 0.53 |
| Prescription drugs, mean (SE), No. | 4.8 (1.1) | 4.7 (1.1) | 0.86 |
| Chronic conditions, mean (SE), No. | 2.0 (1.1) | 1.9 (1.1) | 0.76 |